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Abstract—The understanding of dose/side-effects relationships
in prostate cancer radiotherapy is crucial to define appropriate
individual’s constraints for the therapy planning. Most of the
existing methods to predict side effects do not fully exploit
the rich spatial information conveyed by the three-dimensional
planned dose distributions. We propose a new classification
method for three-dimensional individuals’ doses, based on a
new semi-nonnegative ICA algorithm to identify patients at
risk of presenting rectal bleeding from a population treated for
prostate cancer. The method first determines two bases of vectors
from the population data: the two bases span vector subspaces,
which characterize patients with and without rectal bleeding,
respectively. The classification is then achieved by calculating
the distance of a given patient to the two subspaces. The results,
obtained on a cohort of 87 patients (at two years follow-up)
treated with radiotherapy, showed high performance in terms of
sensitivity and specificity.
Index Terms—semi-nonnegative ICA algorithm, feature extrac-
tion, prostate cancer, rectal bleeding, side effects, radiotherapy,
classification.
I. INTRODUCTION
Modern RadioTherapy (RT) techniques, such as Intensity
Modulated RT (IMRT) and Image Guided RT (IGRT), may
allow the increase of dose delivered to the target volume
(tumor) [1] but at the expense of the risk of toxicity since
neighboring organs may also be over-irradiated [2]–[4]. In the
case of prostate cancer, the considered organs at risk are the
bladder and the rectum for which the toxicity events may
vary in time and complexity. For instance, rectal bleeding,
stool loosing and/or urinary incontinence can arise several
years after the end of the treatment. Hence, being able to
identify a patient who likely will suffer from toxicity events
at the early planning stage is of paramount importance in
terms of treatment optimization. Understanding the dose-
toxicity relationships is, thus, a central question to manage
the therapy by selecting appropriate constraints at the inverse
planning step in IMRT. Most of the current methods addressing
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the dose-toxicity relationship issues are based on the Three-
Dimensional planned Dose Distribution (3DpDD) via the
Dose-Volume Histograms (DVHs) [5] by using radiobiological
Normal Tissue Complication Probability (NTCP) models [6]–
[9]. In Prostate Cancer RadioTherapy (PCRT) context, differ-
ent studies have shown a significant correlation between dose,
volume and rectal toxicity [10]–[17]. Nevertheless, these stud-
ies present some limitations since they have been solely based
on the DVHs: i) the use of DVHs require large databases for
the estimation of population specific parameters, ii) different
3DpDD may have similar DVH, and iii) methods based on
DVHs lack spatial accuracy, since they considered the organs
as having homogeneous radio-sensitivity.
Recently, methods have been proposed which addressed the
use of Three-Dimensional (3D) voxel information. Buettner
et al. [18], [19] proposed a parameterized representation of
the 3DpDD to describe its geometrical properties, such as
the eccentricity and its lateral and longitudinal extents. Af-
ter a first feature extraction step, a formal classification is
performed using Support Vector Machine (SVM). However,
in this method, there is still a preceding individual feature
computation step, which does not jointly use the voxel infor-
mation across the whole population. Exploiting the rich voxel
information may be hampered by the large inter-individual
anatomical variability. If all the voxel dose information are
to be analyzed across the population, a previous anatomical
alignment and dose mapping into a common spatial coordinate
system is performed. This is particularly challenging due to
the poor soft-tissue contrast, large inter-individual variability,
and differences in bladder and rectum filling [20], but some
registration methods have been proposed tackling this prob-
lem [21]. Following this idea, population analysis and voxel-
wise comparison of 3DpDD has been performed in [22], [23].
Although these approaches enable the identification of 3D
anatomical patterns which may be responsible for toxicity,
they do not perform any formal classification or a prediction
of toxicity for a given individual. Thus, new methods aimed at
jointly taking advantage of the 3DpDD, that reveal the subtle
correlation between local dose and toxicity at a voxel level to
classify patients at risk, are still to be devised.
Assuming perfectly aligned 3D images, the Principal Com-
ponent Analysis (PCA) can be used to extract features for clas-
sification from voxel information by considering each voxel
as a decorrelated observation. For instance, PCA has been
2performed for feature extraction and dimensionality reduction
in the identification of Alzheimer’s disease [24] using positron
emission tomography images. PCA computes an orthogonal
basis by maximizing the variance of the coordinates of each
3D individual image in the subspace spanned by the basis
vectors. In the context of rectal bleeding, PCA is used to
analyze non-rigidly registered dose distributions and classify
bleeding patients [25], [26]. This work aimed at identifying
one basis of orthogonal vectors from 3DpDD of rectal bleeding
and non rectal bleeding patients, allowing good classification
results. However, PCA is limited by the orthogonal constraints
defined in the problem formulation. This constraint can be
relaxed by using more statistical information from 3DpDD,
such as the mutual independence of the signal of interest
(sources) [27]. This leads to the Independent Component
Analysis (ICA) concept [28]. ICA has been successfully
used for extracting linear features combinations [29], [30].
Moreover, in some blind source separation applications, such
as face recognition [31] or tumors classification [32], [33], the
components of the mixing matrix can represent pixels and they
are indeed positive. In order to improve the extraction quality,
this nonnegativity property can be exploited, giving rise to
what we call hereafter the Semi-Nonnegative ICA (SN-ICA).
In our context, the components of the mixing matrix corre-
spond also to the intensity of the dose such as a positive value
(which means delivered energy per mass unit at each voxel).
In this paper, we propose a new classification procedure, based
on a new SN-ICA algorithm, to characterize rectal bleeding
on groups of patients treated by radiotherapy. More precisely,
this procedure aims at determining two bases from 3DpDD:
the first basis characterizes the rectal bleeding and the second
one corresponds to the non rectal bleeding patients. The classi-
fication is achieved by projecting a new 3D individual planned
Dose Distributions (pDD) onto both subspaces spanned by
the two vector bases. The new patient is thus classified using
the smaller distance to both subspaces. Tests on real clinical
database of 87 patients (13 of them presented rectal bleeding
within a 2-year follow-up) and the comparison with some
classical methods showed high performance of the proposed
method in terms of sensitivity and specificity. The obtained
results revealed spatial relationships between the 3DpDD and
treatment outcome, paving a way for the prediction of toxicity
in PCRT.
II. THE CLASSIFICATION PROCEDURE
Our classification procedure involves three steps, namely
the preprocessing step, the training step and the classification
step, which are summarized in figure 1.
1) Preprocessing step: It is divided into two sub-steps: i)
data registration and ii) data structuring.
a) Data registration: In order to perform a voxel based
statistical analysis, an accurate mapping of the dose distri-
bution received by the rectum is required. Patient’s planning
CT and dose distributions are non-rigidly registered into a
common coordinate system. This non-rigid registration ap-
proach advantageously combines information available at the
planning step, namely the 3D anatomical data (individual
CTs) and organ manual delineations. Thus, euclidean distance
maps from organs boundaries are built and combined with
CT scans to perform a non-rigid demons registration method
based warping as described in [22]. Regarding the single
template, it was selected as the individual closest to all of the
remaining individuals. This typical individual was found by
affinity propagation clustering among a subgroup of randomly
selected patients from the whole database [22]. In our study
we focus on rectal bleeding and only the registered 3DpDD
within the rectum is considered.
b) Data structuring: Each individual’s 3DpDD is ar-
ranged in a vector by vertically concatenating the rows of
all slices. Thus, we obtained an (N × P (1)) matrix X(1) for
patients with rectal bleeding and an (N × P (2)) matrix X(2)
for those without rectal bleeding: P (1), P (2) and N represent
the number of individuals with rectal bleeding, the number of
individuals without rectal bleeding and the number of voxels,
respectively.
2) Training step: In this step we first identify from the data
two vector bases, A(1) = (a(1)1 , . . . ,a
(1)
F (1)
) and
A(2) = (a
(2)
1 , . . . ,a
(2)
F (2)
), spanning two vector subspaces,
A
(1) and A(2), that characterize patients with and without
rectal bleeding, respectively. The dimensions F (i) (i = {1, 2})
are usually lower than P (i). Secondly, we construct from A(1)
and A(2) two sets of subspaces, called ε(1) = {ε(1)1 , . . . , ε
(1)
K }
and ε(2) = {ε(2)1 , . . . , ε
(2)
L }. More precisely, we respectively
built from A(1) and A(2) two sets I(1) = {E(1)1 , . . . ,E
(1)
K }
and I(2) = {E(2)1 , . . . ,E
(2)
L } (where E(1)k , k ∈ {1, . . . ,K}
is a sub-basis of rank R(1), with R(1) ≤ F (1), and E(2)ℓ , ℓ ∈
{1, . . . , L}, is of rank R(2), with R(2) ≤ F (2)). It is notewor-
thy that each subspace ε(i)j is spanned by a vector subbasis
E
(i)
j . Two key questions, that will be discussed in details in
sections III-B and II-3, arise: i) the calculation of A(1) and
A(2), and ii) the choice of the optimal subbases E(1)kopt and
E
(2)
ℓopt
, containing the more informative features of A(1) and
A(2), that better divide the patients in rectal and non rectal
bleeding groups.
3) Classification step: In order to classify a new patient
belonging to the testing set, its 3D individual pDD, xnew,
is orthogonally projected onto all subspaces of ε(1) and ε(2),
characterizing the two groups (patients with and without rectal
bleeding) as follows:
g
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k
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ℓ (E
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(2)
ℓ
T
. Afterward, the euclidean distances
between xnew and its orthogonal projections are computed by:
d
(1)
k = ‖xnew − g
(1)
k ‖ (1 ≤ k ≤ K) (3)
d
(2)
ℓ = ‖xnew − g
(2)
ℓ ‖ (1 ≤ ℓ ≤ L) (4)
3Fig. 1. The three steps of the classification procedure: 1) the preprocessing step: the data are registered and structured, 2) the training step: the two vector
bases spanning the rectal and non rectal bleeding subspaces are calculated, and 3) the classification step: the new 3DpDD is orthogonally projected onto both
subspaces and the new patient is classified in the closest group.
To select the optimal couple (E(1)kopt ,E
(2)
ℓopt
), we maximize the
following criterion:
(d
(1)
kopt
, d
(2)
ℓopt
) = argmax
(d
(1)
k
,d
(2)
ℓ
)
(d
(1)
k − d
(2)
ℓ ) (5)
with 1 ≤ k ≤ K and 1 ≤ ℓ ≤ L. Finally, the new patient is
classified as belonging to the closest group: if d(1)kopt < d
(2)
ℓopt
,
we will deduce that he belongs to the rectal bleeding group.
Otherwise, he is classified as non rectal bleeding patient. It is
interesting to note that this step is performed by the euclidean
norm and does not require any evolutive classification method.
III. PROBLEM FORMULATION AND METHOD
This section presents the new SN-ICA algorithm that will
be used to estimate the vector bases A(1) = (a(1)1 , . . . ,a
(1)
F (1)
)
and A(2) = (a(2)1 , . . . ,a
(2)
F (2)
), that characterize patients with
and without rectal bleeding, respectively. In the sequel, we
present the algorithm in general case, namely to estimate the
basis A(i), whatever i ∈ {1, 2}.
A. Problem formulation
As explained in section II-1, X(i) contains the 3DpDD of all
patients belonging to the ith group (each individual’s 3DpDD
is arranged in a column vector). More particularly, assume that
each individual 3DpDD, x(i)[m] = [x(i)1 [m], . . . , x
(i)
N [m]]
T
, is
one realization of a N -dimensional random process {x(i)[m]}.
x(i)[m] is modeled as an linear combination of basis vectors
(a
(i)
1 , . . . ,a
(i)
F (i)
), whose weights are denoted by, s(i)[m] =
[s
(i)
1 [m], . . . , s
(i)
F (i)
[m]]T . In our context, each component of
A(i) represent the intensity value of the dose and it is
indeed positive. In addition, we assume that the coordinates
of x(i)[m] in basis A(i), namely the elements of s(i)[m] , are
independent. So, the problem we tackle in this paper can be
formulated using the Semi-Nonnegative ICA (SN-ICA) one
[34], [35].
Problem 1: Given one realization of a real random vector
process {x(i)[m]}, find an (N × F (i)) matrix A(i) and
one realization of a F (i)-dimensional source random process
{s(i)[m]}, such that for each index m:
x(i)[m] = A(i)s(i)[m], where A(i) has nonnegative compo-
nents and s(i)[m] has statistically independent components.
B. SN-ICA algorithm
As depicted in figure 1, the SN-ICA method consists, first,
in a nonnegative compression and rank estimation step which
aims to reduce the dimension of the observation space. The
second step, based on the ELS-ALSsquare algorithm [34],
estimates the bases A(i), (i ∈ {1, 2}) from the compressed
observations.
1) The nonnegative compression and rank estimation: In
order to reduce the dimension of the observation space, the
nonnegative compression method truncates the N -dimensional
vector x(i)[m] into a vector x˜(i)[m] of rank F (i) ≪ N . The
compressed observations are expressed as follows:
x˜(i)[m] = W (i)Tx(i)[m] (6)
4where W (i) of size (N×F (i)) is the compression matrix. For
the ICA model without nonnegative constraint, the columns of
W (i) are the eigenvectors corresponding to the F (i) largest
eigenvalues of the covariance matrix E(x(i)[m]x(i)[m]T) −
E(x(i)[m])E(x(i)[m]T) and the estimate of the rank, F (i),
is determined by the number of eigenvalues not exceedingly
close to zero [36]. However, in our model, such a method can-
not guarantee the nonnegativity of the compressed basis matrix
A˜
(i)
= W (i)TA(i), since generally W (i) is not nonnegative.
It is possible to transform W (i) into the nonnegative orthant
by column-pair rotations [37], [38].
In practice, the only use of the rotation transformation is
not sufficient to guarantee the nonnegativity of W (i). This is
done by the introduction of the shearing transformation on the
pairs of columns of W (i) (see Appendix A for details). Thus,
if W (i) is nonnegative, the compressed matrix A˜(i) of size
(F (i) × F (i)) preserves the nonnegativity property of A(i).
The rank is also estimated by singular value decomposition
[36], as in the common compression. So, the compressed
3D individual pDD vector, x˜(i)[m] still follows the SN-ICA
model: x˜(i)[m] = A˜(i)s˜(i)[m].
2) The SN-ICA based ELS-ALSsquare algorithm: The SN-
ICA algorithm exploits some interesting properties enjoyed
by cumulants in the presence of mixed independent processes
[34]. Let Cn1,n2,n3,x˜(i) and Cn1,n2,n3,n4,x˜(i) be the entries
of the Third Order (TO) and Fourth Order (FO) cumulant
arrays, C3, x˜(i) and C4, x˜(i) , respectively, of a zero-mean F (i)-
dimensional random vector {x˜(i)[m]}. Under the assumptions
made in SN-ICA problem and due to the multi-linearity
property of cumulants, we have:
Cn1,n2,n3,x˜(i) =
F (i)∑
f=1
A˜
(i)
n1,f
A˜
(i)
n2,f
A˜
(i)
n3,f
Cf,f,f,s˜(i) (7)
Cn1,n2,n3,n4,x˜(i) =
F (i)∑
f=1
A˜
(i)
n1,f
A˜
(i)
n2,f
A˜n3,f A˜
(i)
n4,f
Cf,f,f,f,s˜(i) (8)
where Cf,f,f,s˜(i) is the (f, f, f)-th element of the TO cumulant
array of {s˜(i)[m]}, Cf,f,f,f,s˜(i) is the (f, f, f, f)-th element of
the FO cumulant array of {s˜(i)[m]} and F (i) is the number
of extracted sources. Note that the dimensions of C3, x˜(i) and
C4, x˜(i) are (F
(i)×F (i)×F (i)) and (F (i)×F (i)×F (i)×F (i)),
respectively. We propose to merge together the entries of the
TO and FO cumulant arrays in the rectangular matrix T (3,4)
x˜
(i) of
size (F (i)+(F (i))2×(F (i))2). The (i1, i2)-th entry, T (3,4)
i1,i2,x˜
(i)
of T (3,4)
x˜
(i) is given by:
T
(3,4)
i1,i2,x˜
(i) =

Cn1,n2,i1,x˜(i) for any i1 ∈ {1, . . . , F
(i)}
with i2=n1+F (i)(n2−1)
Cn1,n2,n3,n4,x˜(i) with i1=n4+F
(i)n3
and i2=n2+F (i)(n1− 1)
for any i1 ∈ {F (i)+1, . . . ,F (i)+(F (i))2}
By inserting (7) and (8), we obtain the following algebraic
structure of the matrix T (3,4)
x˜
(i) :
T
(3,4)
x˜
(i) = C˜
(i)
((A˜
(i)
)⊙2)T + V (i) (9)
with C˜
(i)
= [C3,s˜(i)A˜
T,C4,s˜(i)(A˜⊙A˜)
T]T where the matri-
ces C3,s˜(i) = diag([C1,1,1,s˜(i) , · · · , CF (i),F (i),F (i),s˜(i) ]) and
C4,s˜(i) = diag([C1,1,1,1,s˜(i) , · · · , CF (i),F (i),F (i),F (i),s˜(i) ]) of
size (F (i) × F (i)) are diagonal. The symbol ⊙ stands for
the Khatri-Rao product (column-wise Kronecker product) and
we denote: (A˜(i))⊙2=A˜(i)⊙A˜(i). The matrix V (i) represents
the model residual. As a way of treating the nonnegativity
constraint of the matrix A˜(i) in the SN-ICA model, one can
resort to the square change of variable A˜(i) = (B˜(i))⋄2,
with B(i) ∈ RF (i)×F (i) (where (B(i))⋄2 = B(i) ⋄ B(i) and
the symbol ⋄ represents the Hadamard product (element-wise
product)). The SN-ICA problem is, then, totally characterized
by the following objective function:
f(B˜
(i)
, C˜
(i)
) = ‖T
(3,4)
x˜
(i) −C˜
(i)
(((B˜
(i)
)⋄2)⊙2)T‖2F (10)
where the couple of variables (B˜(i),C˜(i)) belongs to the
open set R(F (i)+(F (i))2)×F (i)×RF (i)×F (i) and the symbol ‖.‖F
denotes the Frobenius norm. It is worth noting that the
nonnegative constraint is circumvented by means of the square
change of variable, leading to unconstrained problem.
a) Alternating Least Squares (ALS) procedure: ALS pro-
cedure is proposed, in order to minimize (10), taken into ac-
count several advantages, such as the decomposition accuracy,
the numerical complexity and the memory requirements [39].
The ALS principle is to reduce the non-linear minimization
problem of f (10) to several coupled linear least-squares
subproblems. To do so, we choose to alternatively minimize
the cost function w.r.t. B˜(i) and C˜(i), optimizing w.r.t. one
variable while keeping the other one fixed. Then, we solve
sequentially, for the iteration it, both following subproblems:
B˜
(i)
it+1=argmin
B˜(i)
fB(i) =argmin
B˜(i)
∥∥∥T (3,4)
x˜
(i) −C˜
(i)
it ((A˜
(i)
)⊙2)T
∥∥∥2
C˜
(i)
it+1=argmin
C˜(i)
fC˜(i) =argmin
C˜(i)
∥∥∥T (3,4)
x˜
(i) −C˜
(i)
((A˜
(i)
it+1)
⊙2)T
∥∥∥2
with A˜(i)= (B˜(i))⋄2, and where fB˜(i) and fC˜(i) depend only
on one free variable, B˜(i) and C˜(i), respectively. The solution
B˜
(i)
it+1 of the first subproblem can be obtained by alternatively
solving fB(i) w.r.t. all components of B˜
(i)
. So, we introduce
f
B˜
(i)
m,n
: B˜
(i)
m,n 7→ fB(i)(B˜
(i)), where B˜(i)m,n is the (m,n)-
th component of B˜
(i)
. The element of B˜
(i)
it+1 is achieved
by vanishing the derivative denoted f ′
B˜
(i)
m,n
. It is noteworthy
that this derivative is a polynomial in variable B˜(i)m,n and the
expression is given by:
f ′
B˜
(i)
m,n
(B˜(i)m,n) = α7(B˜
(i)
m,n)
7 + α3(B˜
(i)
m,n)
3 + α1B˜
(i)
m,n (11)
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α1 =− 2(A˜
(i)
it
T(M
(i)
it +N
(i)
it ))n,(n−1)F (i)+m−
4(A˜
(i)
it (((A˜
(i)
it )
TA˜
(i)
it ) ⋄ ((C˜
(i)
it )
TC˜
(i)
it )))m,n−
4A˜(i)m,n(((C˜
(i)
it )
TC˜
(i)
it ((A˜
(i)
it )
T)⋄2)+
((A˜
(i)
it )
TA˜
(i)
it )n,n((C˜
(i)
it )
TC˜
(i)
it )n,n−
(A˜(i)m,n)
2((C˜
(i)
it )
TC˜
(i)
it )n,n)
− 2A˜(i)m,n(M
(i)
it +N
(i)
it )m,(n−1)F (i)+m
α3 =− 2(M
(i)
it +N
(i)
it )m,(n−1)F (i)+m+
4((A˜
(i)
it )
⋄2(C˜
(i)
it )
TC˜
(i)
it )m,n+
4(((A˜
(i)
it )
TA˜
(i)
it )n,n((C˜
(i)
it )
TC˜
(i)
it )n,n−
8(A˜(i)m,n)
⋄2((C˜
(i)
it )
TC˜
(i)
it )n,n
α7 =4((C˜
(i)
it )
TA˜
(i)
it )n,n
where M (i)it =Mat
(F (i)×1,(F (i))2)(vec(T
(3,4)
x˜
(i) )
TC˜
(i)
it ) and
N
(i)
it = Mat
(F (i)×F (i),F (i))(M
(i)
it
T). Note that, MatI×J,K
is the block matrix rearrangement operator of a (IK ×
J) matrix, such as Mat(I×J,K)([Z1T,Z2T, · · · ,ZKT]T) =
[Z1,Z2, · · · ,ZK ], with K blocks of size (I × P ). A matrix
computation of the previous coefficients is performed allowing
for an effective implementation in matrix programming envi-
ronments. The first solution is B˜(i)mn = 0 and for the others, we
can search by computing the positive roots of a third degree
polynomial defined by:
γ
A˜
(i)
mn
(A˜(i)mn) = (A˜
(i)
mn)
3 +
α3
α7
A˜(i)mn +
α1
α7
with A˜(i)mn = (B˜(i)mn)2. Then, an analytical root can be
computed using Cardono’s method and choosing the positive
root, which minimizes the cost function, f ′
B˜
(i)
mn
. This step is
achieved for all components of B(i)it+1. Then, the solution of
the second subproblem is well-known and given by
C˜
(i)
it+1 = T
(3,4)
x˜
(i) ((A˜
(i)
it+1 ⊙ A˜
(i)
it+1)
♯)T [40].
b) Line search procedure: The ALS procedure has some
known drawbacks, as slow convergence, in the context of
ill-conditioned factors or high collinearity, and as sensitivity
to initialization. The algorithm can stay trapped in a local
minimum or cycle [41], [42]. Line search scheme has been
used in order to exit from them and so, to accelerate the
ALS algorithm [42]–[46]. It consists of the linear interpolation
of the loading matrices, B˜(i) and C˜(i), from their previous
estimates:
B˜
(i)
new = B˜
(i)
it−1 + µ
B˜(i)
it G
B˜(i)
it (12)
C˜
(i)
new = C˜
(i)
it−1 + µ
C˜(i)
it G
C˜(i)
it (13)
where GB˜
(i)
it =B˜
(i)
it+1−B˜
(i)
it and GC˜
(i)
it =C˜
(i)
it+1−C˜
(i)
it represent
the search directions or the directions of the cycle, computed
by the ALS procedure, and where µB˜(i)it and µC˜
(i)
it are the
stepsizes along those directions. The line search step is per-
formed before applying the ALS iteration and the interpolation
matrices, B˜(i)new and C˜
(i)
new, are used as starting values for the
ALS update rules, at the iteration it, instead of B˜(i)it and C˜
(i)
it .
After inserting the update rules of B˜(i) and C˜(i) in (10), both
stepsizes µB˜(i)it and µC˜
(i)
it can be computed by minimizing the
following function:
ϕ(µB˜
(i)
, µC˜
(i)
)=
∥∥∥T (3,4)
x˜
(i) −C˜
(i)
new((A˜
(i)
new)
⊙2)T
∥∥∥2
F
(14)
w.r.t. µB˜
(i)
and µC˜(i) and where A˜(i)new = (B˜
(i)
new)
⋄2
. This
can be done approximately or exactly [41], [43]. We propose
an optimal procedure, allowing to accelerate maximally the
convergence. It searches the optimal stepsizes that corresponds
to the real roots of a polynomial defined in equation (14).
The details of such a procedure are given in in Appendix B.
Nevertheless, this procedure can considerably increase the
ALS numerical complexity per iteration. Then, to have a good
compromise between effectiveness and numerical complexity,
it is better to calculate the optimal stepsizes, µB˜it and µC˜it ,
every k iterations with k > 1. Finally, after the ELS-
ALSsquare step, the vector basis A(i) is identified as follows:
A(i) = (W (i))−TA˜
(i)
, with A˜(i) = (B˜(i))⋄2 and W (i)
computed in the section III-B1.
IV. DATABASE AND VALIDATION RESULTS
A. Database
A total of 87 patients treated for prostate cancer with IMRT
is used to evaluate our classification procedure. The used
treatment planning system is Pinnacle V7.4 (Philips Medical
System, Madison, WI). The total prescribed dose is 46 Gy to
the seminal vesicles delivered in 4.6 weeks, and 80 Gy to the
prostate delivered in 8 weeks. The standard fractionation was
of 2 Gy per fraction. The whole treatment and dose constraints
are complied with GETUG 06 recommendations as described
in [47]. The constraints are a maximal dose and a V72 Gy1
lower than 76 Gy and 25% for the rectal wall. The size of
the images is 512× 512 pixels in the axial plane, with 1mm
image resolution and 2mm slice thickness. For each patient,
the organs are manually contours by the same expert, following
the same standard clinical protocol in radiotherapy. The expert
contoured the clinical target (prostate and seminal vesicles)
and the organs at risks ( the bladder and the rectum). For
each patient, the prescribed dose is computed in a standard
treatment planning system step and then resampled into the
CT native space. The prostate received homogeneously 80
Gy while the nearby organs at risks received lesser and
heterogeneous dose. The delivery was guidedF by means of an
IGRT protocol, with cone beam CT images or two orthogonal
images (kV or MV imaging devices), using gold fiducial
markers in 57% of patients. The events were defined as rectal
bleeding (≥ Grade 1), at least one episode occurring between
6 months and 2 years after Radiation Therapy. Patients with
a history of hemorrhoids were not allowed to be scored as
Grade 1 bleeding. Rectal toxicity was scored according to the
Common Terminology Criteria for Adverse Events (CTCAE)
version 3.0. Out of 87 patients, 13 presented rectal bleeding
(≥grade1) with a follow-up time of two years.
1(volume receiving at least 72Gy)
6B. Validation
1) Evaluation scheme: Because of the reduced number of
patients in our database (especially those suffering from rectal
bleeding, 13 patients), a leave-one-out cross validation is per-
formed to evaluate the proposed classification method. A 3D
individual pDD is extracted (validation data) and our method
described in section II is applied to the 86 remaining 3DpDD
(training data). This is repeated such that each patient is used
as a test sample. The performance of the method is evaluated
in terms of Sensitivity (Se) and Specificity (Sp). The Se
value assesses the probability of patients with rectal bleeding
being correctly classified and the Sp value corresponds to the
probability of other patients who are correctly identified as
without rectal bleeding.
2) Results: In order to study the performance of the pro-
posed procedure, we first discuss the impact of the ranks F (1)
and F (2) of A(1) and A(2). Then we evaluate the interest of
selecting the more informative features, i.e. E(1)kopt and E
(2)
ℓopt
.
Eventually, a comparative study with some classical methods
is proposed.
a) Influence of the ranks F (1) and F (2): Figures 2(a)
and 2(b) show the Se and Sp values as a function of F (1)
and F (2), varying from 3 to 7. In this experiment, the whole
vector bases derived from the SN-ICA algorithm are used.
In other word we assume that E(i)opt = A(i), i = {1, 2}. We
remark that, for the high values of F (1) (5 ≤ F (1) ≤ 7) and
F (2) (3 ≤ F (2) ≤ 4), all patients are classified in the group
of rectal bleeding: Se = 1 and Sp ≃ 0. In contrary, when
F (1) is low (3 ≤ F (1) ≤ 4), we obtain Se ≃ 0 and Sp = 1
(all patients are viewed as no rectal bleeding ones). We also
observe that, for 6 ≤ F (1) ≤ 7 and 4 ≤ F (2) ≤ 5, we obtained
the quite good results. The best trade off between Se and Sp
values seems to be achieved for (F (1), F (2)) = (7, 5): only 2
patients with rectal bleeding (Se=0.84) and 2 patients without
rectal bleeding (Sp=0.97) are not well classified.
b) Influence of feature selection: In this experiment, the
procedure of the feature selection is evaluated. Figures 3(a)
and 3(b) display the Se and Sp values when varying F (1) and
F (2) and for (R(1), R(2)) = (1, 1) (i.e. only one vector of two
bases A(1) and A(2) are selected to form the optimal vector
subbases E(1)kopt and E
(2)
ℓopt
). We show that Sp is equal to 1
whatever the number of ranks, F(1) and F(2). In other words,
all patients without rectal bleeding are well classified. The
procedure allows to perfectly classify the two groups (Se = 1
and Sp = 1) for many couples of ranks. More particularly, it is
interesting to note that for (F(1), F(2)) = (4, 4), estimated by
the proposed nonnegative compression algorithm [36] (section
III-B1), the obtained performance is also perfect.
c) Comparison with classical algorithms: The proposed
SN-ICA algorithm was also compared to: i) four unsupervised
classification approaches, namely the PCA-based method pre-
sented in [26], a classical ICA-based algorithm [48], a Non-
negative Matrix Factorization (NMF) based approach [49] and
a K-means clustering algorithm [50], and ii) two supervised
methods, namely Linear Discriminant Analysis (LDA) [51]
and Support Vector Machine (SVM) [52]. All these methods
also take the advantage of the spatial information through the
use of the registered 3DpDD. The obtained results (table I)
show that the SN-ICA classification method outperforms all
the other methods.
TABLE I
COMPARISON OF UNSUPERVISED CLASSIFICATION TECHNIQUES AND
SUPERVISED APPROACHES
Methods Sensitivity (Se) Specificity (Sp)
SN-ICA 1 1
Classical ICA 0.28 1
NMF 1 0.42
PCA 0.76 1
LDA 0.53 0.64
SVM 0.23 0.81
K-means 0.46 0.35
V. DISCUSSIONS AND FUTURE WORK
Results demonstrated the robustness of the SN-ICA algo-
rithm for the classification of 3DpDD. Although the method
was herein applied to the analysis of doses for predicting
radiotherapy side-effects, it can also be directly applied to
different classification problems of non-rigidly aligned 3D
voxel data.
The identification of bases combined with orthogonal pro-
jection improves the results with respect to the use of only the
orthogonal projections onto the raw population data X(1) and
X(2). Indeed, using our simple classification scheme without
any vector basis identification leads to very poor performances,
since most of the patients were classified as rectal bleeding
(Se = 1 and Sp = 0.02). In addition, all the supervised
methods (which do not explicitly identify vector bases) give
poor results (see table I).
Two other major contributions in this paper are: i) the
consideration of non-negativity constraints together with in-
dependency, and ii) the nonnegative compression. The non-
negativity is in line with the positive character of dose, which
is meaningful for this application. The SN-ICA algorithm
allows for the combination of nonnegative constraints with
independent assumption as opposed to PCA, classical ICA
and NMF methods, which use orthogonality, independence
and nonnegativity constraints, respectively. Regarding the non-
negative compression, it allows for the estimation of the best
basis ranks F (i). Moreover, reducing the dimension of the ob-
servation space, yields an increased computational efficiency,
without degrading the performance of the procedure.
Our classification criterion is based on the euclidean norm
and does not require any evolutive classification method.
In addition to that, a careful selection of more informative
features from the computed bases is also crucial for the classi-
fication. With these data, significantly improved performances
are obtained (Se = 1 and Sp = 1).
The proposed framework also depends on a non-rigid
marching organ and CTs scans. The exploitation of euclidean
distance maps from organ boundaries allowed for careful
matching of the dose near to the rectal wall. Nevertheless,
further work will be investigated to enhance the alignment of
all structures. Another key point to consider, in future studies,
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Fig. 2. Performance of the multivoxel-based Semi-Nonnegative ICA (SN-ICA) feature extraction for different couples of ranks without selection of features.
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Fig. 3. Performance of the multivoxel-based Semi-Nonnegative ICA (SN-ICA) feature extraction for different couples of ranks and selection of one feature.
relies on the optimal template selected from the database to
be representative of a given population.
Although the results are promising in terms of performance,
concerning the clinical application, the results shall be con-
firmed with larger databases. Toxicity prediction has been
addressed by a large number of studies using DVHs [6]–[9],
which differ from our proposed approach. Despite the lack of
spatial accuracy, these well-established methods provide good
prediction results. In future work, a thorough validation against
those models will be performed. One of the issues for this
comparison to be carried out lies in the need of large cohorts
to estimate the population specific parameters. As opposed to
them, the proposed method exploits the rich spatial informa-
tion encoded in the 3DpDD yielding a perfect classification.
The good performance reveals that classifying rectal bleeding
and non rectal bleeding patients from a population treated for
prostate cancer is possible. Clearly, in this study we don’t
claim that the 3DpDD is the only factor responsible of side
effects. Obviously, it is well known that the toxicity is also
related to specific factors of an individual [16], [17], [53],
[54], such as radio-sensitivity, personal medical history, age,
concomitant treatment, etc. Further works should also consider
the inclusion of these individual’s clinical variables that may
be involved in toxicity as an additional criterion within the
classification.
VI. CONCLUSION
In this work, we have proposed a new method for classifying
patient at risk of suffering from rectal bleeding after prostate
cancer radiotherapy. The proposed approach is based on a new
SN-ICA algorithm, which allows for the extraction of more
informative features from the 3D planning Dose Distributions
(3DpDD). The method exploits the rich spatial information
conveyed by the 3DpDD thanks to the determination of two
bases for both rectal bleeding and non rectal bleeding patients.
The classification is then achieved by orthogonally projecting
a 3D individual test onto both subspaces spanned by the more
informative vectors. The test patient is thus classified using
an euclidean distance. A comparative study demonstrates the
performance of our method, which provides a new means of
8predicting toxicity. This framework may in turn be used for
improving the therapy by introducing new constraints within
the IMRT planning, and the SN-ICA may also constitutes a
promising procedure for processing other image applications
where the nonnegative constraints and the independence as-
sumption are verified.
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APPENDIX A
THE NONNEGATIVE COMPRESSION
The shearing transformation for a pair of columns of W (i),
called w(i)k and w
(i)
ℓ , is defined as follows:
[ŵ
(i)
k , ŵ
(i)
ℓ ] = [w
(i)
k ,w
(i)
ℓ ]
[
1 0
λ 1
]
(15)
where the parameter λ is called a shear factor. Noting that ŵ(i)ℓ
remains unchanged, we consider the following negativeness
measure criterion [38]:
J(λ) =
1
2
I∑
j
(Ŵ
(i)
j,k )
2
1
Ŵ
(i)
j,k
<0
(16)
where 1α<0 =
{
1 if α < 0
0 otherwise
and Ŵ (i)j,k is the (j, k)-
th component of Ŵ
(i)
. The purpose is to find a λ which
minimizes the total sum of squares of negative elements in
ŵ
(i)
k (16). The global optimum λopt is the root of the derivative
of J(λ). However, such a λopt is difficult to obtain analytically,
since the heaviside-step-like function 1α<0 exists in (16). We
propose to compute λ iteratively by a Newton’s method. At
iteration it, the update rule of λ is given by:
λit = λit−1 −
(
∂2J(λit−1)
∂λ2it−1
)−1
∂J(λit−1)
∂λit−1
(17)
where λit−1 is the solution at the previous iteration,
∂J(λit−1)/∂λit−1 and ∂2J(λit−1)/∂λ2it−1 are the first and
second order derivatives of J w.r.t λit−1 which are given as
follows, respectively:
∂J(λit−1)
∂λit−1
=
I∑
j
(W
(i)
j,k+λit−1W
(i)
j,ℓ )W
(i)
j,ℓ 1(W
(i)
j,k
+λit−1W
(i)
j,ℓ
)<0
(18)
and
∂2J(λit−1)
∂λ2it−1
=
I∑
j
(W
(i)
j,ℓ )
2
1
(W
(i)
j,k
+λit−1W
(i)
j,ℓ
)<0
(19)
∂2J(λit−1)/∂λ
2
it−1 = 0 indicates that all the elements of ŵ
(i)
k
have the same sign. Then the above procedure is repeated
with the next columns pair. Several sweeps of this sequential
optimization procedure are necessary to ensure convergence.
More details can be found in [55].
APPENDIX B
THE COMPUTATION OF THE MATRIX F
The function ϕ (14) can be rewritten as follows:
ϕ(µB˜
(i)
, µC˜
(i)
) =
∥∥∥F 0 + F 1µB˜(i) + F 2(µB˜(i))2+
F 3(µ
B˜(i))3 + F 4(µ
B˜(i))4 + F 5µ
C˜(i) + F 6µ
C˜(i)(µB˜
(i)
)+
F 7µ
C˜(i)(µB˜
(i)
)2 + F 8µ
C˜(i)(µB˜
(i)
)3 + F 9µ
C˜(i)(µB˜
(i)
)4
∥∥∥2
F
where:
F 0 = T
(3,4)
x˜
(i) − C˜
(i)
it−1E0 F 1 = −C˜
(i)
it−1E1
F 2 = −C˜
(i)
it−1E2 F 3 = −C˜
(i)
it−1E3
F 4 = −C˜
(i)
it−1E4 F 5 = −G
C˜(i)
it E0 (20)
F 6 = −G
C˜(i)
it E1 F 7 = −G
C˜(i)
it E2
F 8 = −G
C˜(i)
it E3 F 9 = −G
C˜(i)
it E4
with:
E0 = (K0 ⊙K0)
T E1 = (K0 ⊙K1 +K1 ⊙K0)
T
E2 = (K0 ⊙K2 +K1 ⊙K1 +K2 ⊙K0)
T
E3 = (K1 ⊙K2 +K2 ⊙K1)
T E4 = (K2 ⊙K2)
T
and finally:
K0 = A˜
(i)
it−1 = (B˜
(i)
it−1)
⋄2 K2 = (G
B˜(i)
it )
⋄2
K1 = B˜
(i)
it−1 ⋄GB˜(i) +GB˜(i) ⋄ B˜
(i)
it−1 (21)
In order to calculate µB˜(i)it and µC˜
(i)
it , the function ϕ can be
reduced to a compact form as follows:
ϕ(µB˜
(i)
, µC˜
(i)
) = ‖Fu‖
2
F = u
TF TFu (22)
where F = [vec[F 9] ,vec[F 8] , ...,vec[F 1] ,vec[F 0]] is a
((F (i))4+(F (i))3 × 10) matrix, and u = [µC˜(i)(µB˜(i))4,
µC˜
(i)
(µB˜
(i)
)3, µC˜
(i)
(µB˜
(i)
)2, µC˜
(i)
(µB˜
(i)
), µC˜
(i)
, (µB˜
(i)
)4,
(µB˜
(i)
)3, (µB˜
(i)
)2, (µB˜
(i)
), 1]T is a 10-dimensional vector.
The objective function ϕ is a second degree polynomial in
µC˜
(i)
. The optimal stepsize µC˜(i)it is achieved by vanishing
the partial derivative w.r.t. µC˜(i) , then µC˜(i)it is equal to a
rational function in µB˜(i) . The expression of µC˜(i)it is injected
in the equation ∂ϕ/∂µB˜(i) = 0. Consequently, the global
minimum µC˜(i)it can be computed by rooting the numerator of
∂ϕ/∂µB˜
(i)
, which is a 24-th degree polynomial in µB˜(i) and
selecting the root yielding the smallest value of the objective
function ϕ. Then, we infer µC˜(i)it from µB˜
(i)
it .
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